RAC 5.44% $1.65 race oncology ltd

Is this you hypothesising a combination trial for Zantrene and...

  1. 206 Posts.
    lightbulb Created with Sketch. 62
    Is this you hypothesising a combination trial for Zantrene and Zimberelimab because of the Otsuka supply of our anthracycline for our current combination therapy? Or have I missed an actual announcement. Eitherway, exciting prospect!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.